Bioservo Technologies AB Interim Report January – September 2022
Third quarter in figures · Net sales of SEK 1.9 M (2.3) · EBITDA of SEK -9,9 M (-5.1) · EBIT of SEK -10,7 M (-6.3) · Earnings for the period amounted to SEK -10.7 M (-6.3) · Earnings per share before and after dilution amounted to SEK -0.56 (-0.40) · Cash flow from operating activities for the period amounted to SEK -15,8 M (-7.4) First nine months in figures · Net sales of SEK 8.4 M (4.8) · EBITDA of SEK -31.5 M (-22.5) · EBIT of SEK -34.6 M (-26.2) · Earnings for the period was SEK -34,6 M (-26.2) · Earnings per share before and after dilution